By applying mass cytometry to quantify immune cell subsets in the lungs of patients with IPF, researchers demonstrated that CD4+ TRM and CD8+ TRM were increased in the lungs of IPF (136). The gene discussed is CD8A; the disease is idiopathic pulmonary fibrosis.